Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Repro Med Sys Inc (REPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 34,137
  • Shares Outstanding, K 37,930
  • Annual Sales, $ 12,290 K
  • Annual Income, $ -530 K
  • 36-Month Beta -0.36
  • Price/Sales 3.21
  • Price/Cash Flow 141.56
  • Price/Book 4.63
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6350 +44.88%
on 11/17/17
0.9200 unch
on 12/15/17
+0.2200 (+31.43%)
since 11/15/17
3-Month
0.4800 +91.67%
on 09/18/17
0.9200 unch
on 12/15/17
+0.3700 (+67.27%)
since 09/15/17
52-Week
0.3400 +170.59%
on 07/18/17
0.9200 unch
on 12/15/17
+0.5210 (+130.58%)
since 12/15/16

Most Recent Stories

More News
RMS Medical Products Announces New FDA Clearance, Warning Letter Cosed, and Organizational Changes

- Resolution of FDA Warning Letter

REPR : 0.9200 (+2.22%)
RMS Medical Products Posts Strong Results for Three and Seven Months Ending September 30, 2017

REPR : 0.9200 (+2.22%)
RMS Medical Products Closes Four-Month Period Ending June 30, 2017 with Double-Digit Percentage Growth

Repro Med Systems, Inc., dba RMS Medical Products (OTCQX: REPR), announced last week the latest financial results for the four-month period ending June 30, 2017.

REPR : 0.9200 (+2.22%)
RMS Medical Products Posts Strong Results for Four-Month Period Ending June 30, 2017

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced the latest financial results for the four-month period ending June 30, 2017.

REPR : 0.9200 (+2.22%)
RMS to Launch New Social Media Campaign

CHESTER, NY / ACCESSWIRE / May 15, 2017 / Repro Med Systems, Inc., dba RMS Medical Products (OTCQX: REPR) ("RMS" or the "Company"), announced today it will be launching a new social media marketing ...

REPR : 0.9200 (+2.22%)
RMS Changes Fiscal Year End

CHESTER, NY / ACCESSWIRE / April 27, 2017 / Repro Med Systems, Inc., dba RMS Medical Products (OTCQX: REPR) ("RMS" or the "Company"), announced that the Board of Directors approved a change in the Company's...

REPR : 0.9200 (+2.22%)
RMS Establishes New Medical Advisory Council

CHESTER, NY / ACCESSWIRE / April 17, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) ("RMS" or the "Company") announced today it has established a new medical advisory council. The...

REPR : 0.9200 (+2.22%)
RMS Medical Products launches FREEDOM60 Infusion system in Germany

CHESTER, NY / ACCESSWIRE / April 10, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) ("RMS" or the "Company") is pleased to announce that the umbrella organization of the public health...

REPR : 0.9200 (+2.22%)
RMS Announces the Launch of a New Product for Home Infusion

CHESTER, NY / ACCESSWIRE / March 27, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) ("RMS" or the "Company") announced today the successful launch of a new product. The F3CP Variable...

REPR : 0.9200 (+2.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Key Turning Points

2nd Resistance Point 0.9467
1st Resistance Point 0.9333
Last Price 0.9200
1st Support Level 0.8933
2nd Support Level 0.8667

See More

52-Week High 0.9200
Last Price 0.9200
Fibonacci 61.8% 0.6984
Fibonacci 50% 0.6300
Fibonacci 38.2% 0.5616
52-Week Low 0.3400

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.